Arterial Remodeling Technologies
Paris
France
17 articles about Arterial Remodeling Technologies
-
Arterial Remodeling Technologies And Terumo Corporation: Promising Pre-Clinical Data On The Next Generation Drug Eluting Bioresorbable Scaffold
5/21/2015
-
Arterial Remodeling Technologies (ART) Announces CE Mark Clearance For Its Pure Bioresorbable Scaffold
5/18/2015
-
Arterial Remodeling Technologies Signs Structured Buyout Agreement With Terumo Corporation, Validating ART’s Next-Gen Bioresorbable Scaffold
3/27/2014
-
Company Profile for Arterial Remodeling Technologies
9/27/2013
-
Arterial Remodeling Technologies Reports First Human Use of Its Next-Generation Bioresorbable Stent
7/16/2012
-
Arterial Remodeling Technologies Receives Regulatory Approval to Begin First-In-Man "ARTDIVA" Clinical Trial With its Next-generation Bioresorbable Stent
5/15/2012
-
Arterial Remodeling Technologies Reports that its Second-Generation Bioresorbable Stent Promotes Vessel Lumen Enlargement in Post-Angioplasty in Vivo Model
11/2/2011
-
Arterial Remodeling Technologies Reports That its Second-generation Bioresorbable Stent Promotes Vessel Lumen Enlargement in Post-angioplasty in Vivo Model
11/2/2011
-
Arterial Remodeling Technologies to Disclose for the First Time the Novel Design, and New Data, for its Potentially Disruptive Polymer-based Bioresorbable Stent
5/17/2011
-
Arterial Remodeling Technologies Raises $8.5 Million in New Venture Financing Round from Existing Investors Matignon Technologies and Amundi Private Equity Funds, Along with New Investor InnoBio
9/22/2010
-
Arterial Remodeling Technologies Discloses Data From In Vivo Study That Its Stent's Biodegradability Is Quantifiable While Preserving Its Mechanical Strength And Causing Almost No Vessel Inflammation
5/20/2010
-
Arterial Remodeling Technologies To Disclose New Data About Its Bioresorbable Stent At The 9th Annual 'EBR Symposium 2010', May 6th
5/3/2010
-
Arterial Remodeling Technologies To Report That Its Bioresorbable Stent Platform Restores the Remodeling Capacity of Arterial Walls
1/4/2010
-
Arterial Remodeling Technologies Appoints Machiel Van Der Leest as Chief Executive Officer
11/4/2008
-
Bioresorbable Stent Company, Arterial Remodeling Technologies, Appoints Machiel Van Der Leest as Chief Operating Officer
3/24/2008
-
Bioresorbable Stent Company, Arterial Remodeling Technologies, Leases Manufacturing Facility
1/15/2008
-
Bioresorbable Stent Company, Arterial Remodeling Technologies, Raises EUR 5.5 ($7.8) Million in New Venture Financing Round from Investors Matignon Technologies and SGAM Alternative Investments
11/12/2007